December 22, 2021
Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant
Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant
December 15, 2021
Rapid Dose Therapeutics Strengthens Leadership Team with Addition of Rodney Butt & Appoints New Advisory Board Member
Rapid Dose Therapeutics Strengthens Leadership Team with Addition of Rodney Butt & Appoints New Advisory Board Member
December 9, 2021
Rapid Dose Therapeutics Signs Product Supply Agreement with Oakland Health Limited in the United Kingdom
Rapid Dose Therapeutics Signs Product Supply Agreement with Oakland Health Limited in the United Kingdom
November 30, 2021
Rapid Dose Therapeutics Signs Agreement with AB Strategic Ventures for Business Development Advisory Services with First Nations Enterprises
Rapid Dose Therapeutics Signs Agreement with AB Strategic Ventures for Business Development Advisory Services with First Nations Enterprises
November 24, 2021
Rapid Dose Therapeutics Completes Milestone One Million QuickStrip™ Units Shipped to a Single Company
Rapid Dose Therapeutics Completes Milestone One Million QuickStrip™ Units Shipped to a Single Company
November 9, 2021
Rapid Dose Therapeutics Completes Significant Shipment of QuickStrip™ Products to Thrive Cannabis
Rapid Dose Therapeutics Completes Significant Shipment of QuickStrip™ Products to Thrive Cannabis